Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: A 1-year follow-up

Clinical and Experimental Hypertension

Volumn 23, Issue 3, 2001, Pages 189-201

  Suzuki, Hiromichi ^a   Saruta, Takao ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Calcium antagonist; Chronic renal insufficiency; Hypertension; Systolic blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENIDIPINE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; LONG ACTING DRUG;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULOPATHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; SIDE EFFECT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CREATINE; DIHYDROPYRIDINES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0035033904     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100102659     Document Type: Article

References (37)

1. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function
2. Understanding the nature of renal disease progression
3. National high blood pressure education program working group report on hypertension and chronic renal failure
4. Treatment of renal failure and blood pressure
5. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
6. Hypertension in the Elderly Program (SHEP) and Swedish Trial in Old Patients with Hypertension (STOP): The promises and the potential problems
7. Blood pressure and progression of renal failure in the elderly
8. Antihypertensive treatment of patients with proteinuric renal diseases. Risks or benefits of calcium channel blockers?
9. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency
10. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial HOT
11. Benidipine
12. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats
13. Hormonal and renal responses to oral once-daily calcium entry blocker in normotensive and hypertensive persons
14. Effects of benidipine a calcium antagonist, on urinary kallikrein excretion and renal impairment in experimental diabetes
15. Effect of the angiotensin converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
16. Progressive renal disease: Role of race and antihypertensive medications
17. Risk of developing endstage renal disease in a cohort of mass screening
18. Blood pressure and end-stage renal disease in men
19. Early predictors of 15 year end-stage renal disease in hypertensive patients
20. Hypertension-related renal injury: A major contributor to end-stage renal disease
21. The modification of diet in renal disease study: Design methods results from the feasibility study
22. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
23. Evidence for a positive linear relation between blood pressure and mortality in elderly people
24. Mechanism underlying transition from acute glomerular injury to glomerulosclerosis in rat model of nephrotic syndrome
25. ACE inhibitors in renal disease
26. For the Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group: Effect of angiotensin-converting-enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials
27. Protecting the residual renal function: How do ACE inhibitors and calcium antagonists compare?
28. Nephroprotective effect of antihypertensive drugs in essential hypertension
29. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease
30. Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency. A 1-year follow-up
31. For the systolic sypertension in Europe trial: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
32. USRDS 1998 Annual DATA REPORT
33. For the Modification of Diet in Renal Disease Study Group: Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group
34. Conservative treatment to slow deterioration of renal function: Evidencebased recommendations
35. Renal function in the elderly: Results from the European working party on high blood pressure in the elderly trial
36. Efficacy of manidipine in the treatment of hypertension with renal impairment: A multicenter trial
37. Effects of calcium channel blocker, nicardipine, on pressure-natriuresis in Dahl salt-sensitive rats